Current Trials

CM1422s Allergic Rhinitis Study

 Paragon Medical + Dental - Modbury

Seasonal allergic rhinitis (Hay Fever) currently effects 20% of Australians. Fusion are researching a new Nasal Spray that is drug free to preventing allergens from entering the nose.

We are currently seeking the help of healthy adults aged 18-75 who experience Hay Fever.

The study requires participants to attend 3 visits at Paragon Medical + Dental over a period of approximately 31 days.

Upon completion of the study, all eligible participants will be paid for their time.

dandelion2

Eligibility requirements

  • Age: 18-75
  • Sex:
  • Medication: Exclusionary Medications: – Inhaled asthma medications apart from short acting medications (SABAs) such as Ventolin/Salbutamol – Long-term continuous use of H1 antihistamines, topical antiallergic treatment, nasal vasoconstrictors/glucocorticoids – Continuous use of nonsteroidal anti-inflammatory drugs (NSAIDs) (NSAID intermittent use is allowed as relief medication)
  • Medical History: Must have a clinical history of seasonal allergic rhinitis (Hay Fever) Exclusionary Conditions: – Uncontrolled asthma – Acute respiratory infections – Abnormal nasal conditions affecting nasal openness

Overnight Stays

  • Nil

Outpatient Visits

  • 3 visits to clinic

Payment/Remuneration

  • $1,160

How to apply

To register your interest in this trial, please complete this form, or call us on 1800-FUSION (1800 387 466). A Fusion team member will be in contact to discuss your eligibility shortly.